CoChat

Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Open access
Feigin, Valery L, Abajobir, Amanuel Alemu, Abate, Kalkidan Hassen, Abd-Allah, Foad, Abdulle, Abdishakur M, Abera, Semaw Ferede, Abyu, Gebre Yitayih, Ahmed, Muktar Beshir, Aichour, Amani Nidhal, Aichour, Ibtihel, Aichour, Miloud Taki Eddine, Akinyemi, Rufus Olusola, Alabed, Samer, Al-Raddadi, Rajaa, Alvis-Guzman, Nelson, Amare, Azmeraw T., Ansari, Hossein, Anwari, Palwasha, Ärnlöv, Johan, Asayesh, Hamid, Asgedom, Solomon Weldegebreal, Atey, Tesfay Mehari, Avila-Burgos, Leticia, Frinel, Euripide, Avokpaho, G. Arthur, Azarpazhooh, Mahmood Reza, Barac, Aleksandra, Barboza, Miguel, Barker-Collo, Suzanne L, Bärnighausen, Till, Bedi, Neeraj, Beghi, Ettore, Bennett, Derrick A, Bensenor, Isabela M, Berhane, Adugnaw, Betsu, Balem Demtsu, Bhaumik, Soumyadeep, Birlik, Sait Mentes, Biryukov, Stan, Boneya, Dube Jara, Bulto, Lemma Negesa Bulto, Carabin, Hélène, Casey, Daniel, Castañeda-Orjuela, Carlos A., Catalá-López, Ferrán, Chen, Honglei, Chitheer, Abdulaal A, Chowdhury, Rajiv, Christensen, Hanne, Dandona, Lalit, Dandona, Rakhi, de Veber, Gabrielle A, Dharmaratne, Samath D, Do, Huyen Phuc, Dokova, Klara, Dorsey, E Ray, Ellenbogen, Richard G, Eskandarieh, Sharareh, Farvid, Maryam S, Fereshtehnejad, Seyed-Mohammad, Fischer, Florian, Foreman, Kyle J, Geleijnse, Johanna M, Gillum, Richard F, Giussani, Giorgia, Goldberg, Ellen M, Gona, Philimon N, Goulart, Alessandra Carvalho, Gugnani, Harish Chander, Gupta, Rahul, Hachinski, Vladimir, Gupta, Rajeev, Hamadeh, Randah Ribhi, Hambisa, Mitiku, Hankey, Graeme J, Hareri, Habtamu Abera, Havmoeller, Rasmus, Hay, Simon I, Heydarpour, Pouria, Hotez, Peter J, Jakovljevic, Mihajlo (Michael) B, Javanbakht, Mehdi, Jeemon, Panniyammakal, Jonas, Jost B, Kalkonde, Yogeshwar, Kandel, Amit, Karch, André, Kasaeian, Amir, Kastor, Anshul, Keiyoro, Peter Njenga, Khader, Yousef Saleh, Khalil, Ibrahim A, Khan, Ejaz Ahmad, Khang, Young-Ho, Tawfih, Abdullah, Khoja, Abdullah, Khubchandani, Jagdish, Kulkarni, Chanda, Kim, Daniel, Kim, Yun Jin, Kivimaki, Mika, Kokubo, Yoshihiro, Kosen, Soewarta, Kravchenko, Michael, Krishnamurthi, Rita Vanmala, Defo, Barthelemy Kuate, Kumar, G Anil, Kumar, Rashmi, Kyu, Hmwe H, Larsson, Anders, Lavados, Pablo M, Li, Yongmei, Liang, Xiaofeng, Liben, Misgan Legesse, Lo, Warren D, Logroscino, Giancarlo, Lotufo, Paulo A, Loy, Clement T, Mackay, Mark T, El Razek, Hassan Magdy Abd, El Razek, Mohammed Magdy Abd, Majeed, Azeem, Malekzadeh, Reza, Manhertz, Treh, Mantovani, Lorenzo G, Massano, João, Mazidi, Mohsen, McAlinden, Colm, Mehata, Suresh, Mehndiratta, Man Mohan, Memish, Ziad A, Mendoza, Walter, Mengistie, Mubarek Abera, Mensah, George A, Meretoja, Atte, Mezgebe, Haftay Berhane, Miller, Ted R, Mishra, Shiva Raj, Ibrahim, Norlinah Mohamed, Mohammadi, Alireza, Mohammed, Kedir Endris, Mohammed, Shafiu, Mokdad, Ali H, Moradi-Lakeh, Maziar, Velasquez, Ilais Moreno, Musa, Kamarul Imran, Naghavi, Mohsen, Ngunjiri, Josephine Wanjiku, Nguyen, Cuong Tat, Nguyen, Grant, Le Nguyen, Quyen, Nguyen, Trang Huyen, Nichols, Emma, Ningrum, Dina Nur Anggraini, Nong, Vuong Minh, Norrving, Bo, Noubiap, Jean Jacques N, Ogbo, Felix Akpojene, Owolabi, Mayowa O, Pandian, Jeyaraj D., Parmar, Priyakumari Ganesh, Pereira, David M, Petzold, Max, Phillips, Michael Robert, Piradov, Michael A, Poulton, Richie G., Pourmalek, Farshad, Qorbani, Mostafa, Rafay, Anwar, Rahman, Mahfuzar, Rahman, Mohammad HifzUr, Rai, Rajesh Kumar, Rajsic, Sasa, Ranta, Annemarei, Rawaf, Salman, Renzaho, Andre M.N., Rezai, Mohammad Sadegh, Roth, Gregory A, Roshandel, Gholamreza, Rubagotti, Enrico, Sachdev, Perminder, Safiri, Saeid, Sahathevan, Ramesh, Sahraian, Mohammad Ali, Samy, Abdallah M., Santalucia, Paula, Santos, Itamar S, Sartorius, Benn, Satpathy, Maheswar, Sawhney, Monika, Saylan, Mete I, Sepanlou, Sadaf G, Shaikh, Masood Ali, Shakir, Raad, Shamsizadeh, Morteza, Sheth, Kevin N, Shigematsu, Mika, Shoman, Haitham, Silva, Diego Augusto Santos, Smith, Mari, Sobngwi, Eugene, Sposato, Luciano A, Stanaway, Jeffrey D, Stein, Dan J, Steiner, Timothy J, Stovner, Lars Jacob, Abdulkader, Rizwan Suliankatchi, EI Szoeke, Cassandra, Tabarés-Seisdedos, Rafael, Tanne, David, Theadom, Alice M, Thrift, Amanda G, Tirschwell, David L, Topor-Madry, Roman, Tran, Bach Xuan, Truelsen, Thomas, Tuem, Kald Beshir, Ukwaja, Kingsley Nnanna, Uthman, Olalekan A, Varakin, Yuri Y, Vasankari, Tommi, Venketasubramanian, Narayanaswamy, Vlassov, Vasiliy Victorovich, Wadilo, Fiseha, Wakayo, Tolassa, Wallin, Mitchell T, Weiderpass, Elisabete, Westerman, Ronny, Wijeratne, Tissa, Wiysonge, Charles Shey, Woldu, Minyahil Alebachew, Wolfe, Charles D A, Xavier, Denis, Xu, Gelin, Yano, Yuichiro, Yimam, Hassen Hamid, Yonemoto, Naohiro, Yu, Chuanhua, Zaidi, Zoubida, El Sayed Zaki, Maysaa, Zunt, Joseph R, Murray, Christopher J L, Vos, Theo · 2017 · The Lancet Neurology

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index; 9 of the 47 sources its claims cite were checked for support.

Abstract

BACKGROUND: Comparable data on the global and country-specific burden of neurological disorders and their trends are crucial for health-care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study provides such information but does not routinely aggregate results that are of interest to clinicians specialising in neurological conditions. In this systematic analysis, we quantified the global disease burden due to neurological disorders in 2015 and its relationship with country development level. METHODS: We estimated global and country-specific prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost (YLLs), and years lived with disability (YLDs) for various neurological disorders that in the GBD classification have been previously spread across multiple disease groupings. The more inclusive grouping of neurological disorders included stroke, meningitis, encephalitis, tetanus, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual category of other neurological disorders. We also analysed results based on the Socio-demographic Index (SDI), a compound measure of income per capita, education, and fertility, to identify patterns associated with development and how countries fare against expected outcomes relative to their level of development. FINDINGS: Neurological disorders ranked as the leading cause group of DALYs in 2015 (250·7 [95% uncertainty interval (UI) 229·1 to 274·7] million, comprising 10·2% of global DALYs) and the second-leading cause group of deaths (9·4 [9·1 to 9·7] million], comprising 16·8% of global deaths). The most prevalent neurological disorders were tension-type headache (1505·9 [UI 1337·3 to 1681·6 million cases]), migraine (958·8 [872·1 to 1055·6] million), medication overuse headache (58·5 [50·8 to 67·4 million]), and Alzheimer's disease and other dementias (46·0 [40·2 to 52·7 million]). Between 1990 and 2015, the number of deaths from neurological disorders increased by 36·7%, and the number of DALYs by 7·4%. These increases occurred despite decreases in age-standardised rates of death and DALYs of 26·1% and 29·7%, respectively; stroke and communicable neurological disorders were responsible for most of these decreases. Communicable neurological disorders were the largest cause of DALYs in countries with low SDI. Stroke rates were highest at middle levels of SDI and lowest at the highest SDI. Most of the changes in DALY rates of neurological disorders with development were driven by changes in YLLs. INTERPRETATION: Neurological disorders are an important cause of disability and death worldwide. Globally, the burden of neurological disorders has increased substantially over the past 25 years because of expanding population numbers and ageing, despite substantial decreases in mortality rates from stroke and communicable neurological disorders. The number of patients who will need care by clinicians with expertise in neurological conditions will continue to grow in coming decades. Policy makers and health-care providers should be aware of these trends to provide adequate services. FUNDING: Bill & Melinda Gates Foundation.

Overview

CoChat Summary

TL;DR

In GBD 2015, an expanded grouping of neurological disorders was the leading cause group of DALYs and the second-leading cause group of deaths worldwide. Absolute deaths and DALYs rose from 1990 to 2015 despite declines in age-standardised death and DALY rates.

Key findings

  • Neurological disorders caused 250·7 million (95% UI 229·1–274·7) DALYs, 10·2% of global DALYs, and 9·4 million (9·1–9·7) deaths, 16·8% of global deaths, in 2015.
  • The most prevalent neurological disorders were tension-type headache (1505·9 million cases), migraine (958·8 million), medication overuse headache (58·5 million), and Alzheimer’s disease and other dementias (46·0 million).
  • Between 1990 and 2015, deaths from neurological disorders increased by 36·7% and DALYs by 7·4%, even though age-standardised death and DALY rates decreased by 26·1% and 29·7%, respectively.
  • Stroke accounted for the largest proportion of DALYs (47·3%) and deaths (67·3%) among neurological disorders; communicable neurological disorders were the largest cause of DALYs in low-SDI countries, and stroke rates were highest at middle SDI levels.

Methods

  • Systematic analysis for GBD 2015 estimating prevalence, mortality, DALYs, YLLs, and YLDs for an expanded neurological disorder category across 195 countries and territories from 1990 to 2015.
  • Included stroke, meningitis, encephalitis, tetanus, Alzheimer’s disease and other dementias, Parkinson’s disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, brain and nervous system cancers, and a residual other neurological disorders category.
  • Used systematic review of epidemiological data, vital registration and verbal autopsy data, DisMod-MR 2.1 and CODEm modelling, and SDI quintiles with spline regression to examine burden by development level.

Limitations

  • Stated: the analysis assumed that excess mortality in Alzheimer’s disease and other dementias derived from high-quality vital registration countries applied to all other countries and periods.
  • Stated: cause-specific death estimates in most low-income and middle-income countries rely on verbal autopsy, which can identify some neurological disorders but not others; data gaps remain, and epilepsy was the only neurological disorder with data sources for all 21 GBD regions.
  • Stated: secondary epilepsy, long-term neurological consequences of neonatal disorders, traumatic brain injury, and spinal cord injury were excluded; sparse severity data prevented differentiating severity by location or over time except for epilepsy. Evident from the text: estimates depend on modelled adjustments and generalisations from few studies, with uncertainty intervals reported throughout.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(17)30299-5

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Global DALYs by age and neurological disorder in 2015 DALYs=disability-adjusted life-years.
Figure 1 Global DALYs by age and neurological disorder in 2015 DALYs=disability-adjusted life-years.CC BY · PubMed Central
Figure 2 Contribution of various neurological disorders to the overall burden from neurological disorders in 2015 Estimates are for (A) disability-adjusted life-years and (B) deaths.
Figure 2 Contribution of various neurological disorders to the overall burden from neurological disorders in 2015 Estimates are for (A) disability-adjusted life-years and (B) deaths.CC BY · PubMed Central
Figure 3 Age-standardised rates of (A) DALYs and (B) deaths per 100 000 people from all neurological disorders combined in 2015 Data are for both sexes. DALYs=disability-adjusted life-years. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste. Marshall Isl=Marshall Islands. Sol Isl=Solomon Islands. FSM=Federated States of Micronesia.
Figure 3 Age-standardised rates of (A) DALYs and (B) deaths per 100 000 people from all neurological disorders combined in 2015 Data are for both sexes. DALYs=disability-adjusted life-years. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste. Marshall Isl=Marshall Islands. Sol Isl=Solomon Islands. FSM=Federated States of Micronesia.CC BY · PubMed Central
Figure 4 Ranking of age-standardised DALY rates for all neurological disorders by GBD region in 2015 Data are for both sexes. DALYs=disability-adjusted life-years.
Figure 4 Ranking of age-standardised DALY rates for all neurological disorders by GBD region in 2015 Data are for both sexes. DALYs=disability-adjusted life-years.CC BY · PubMed Central
Figure 5 Expected relationship between the Socio-demographic Index and DALY rates for neurological disorders per 100 000 people between 1990 and 2015 Age-standardised disability-adjusted life-years (DALYs) per 100 000 people (A) by sex; (B) all-age DALY rate per 100 000 by sex; and (C) age-standardised rate per 100 000 by years of life lost (YLLs) and years lived with disability (YLDs).
Figure 5 Expected relationship between the Socio-demographic Index and DALY rates for neurological disorders per 100 000 people between 1990 and 2015 Age-standardised disability-adjusted life-years (DALYs) per 100 000 people (A) by sex; (B) all-age DALY rate per 100 000 by sex; and (C) age-standardised rate per 100 000 by years of life lost (YLLs) and years lived with disability (YLDs).CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 1 Not valid · 22 Not checked · 136 Own results and interpretations

104 more claims

Create a free account to see all 165 claims and to verify the 38 references still open.

See all claims — free account
  • Probably not a substantial claim. 21
  • It may state two separate claims as one. 40

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 64 references

Research works printed but not linked: 1

  1. Turnbull, 2001, Epidemiology of tetanus in New Zealand reinforces value of vaccination, NZ Public Health Rep, 8, 57

Cited by

See all 2,275

Metadata

Authors
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Akinyemi, R. O., Alabed, S., Al-Raddadi, R., Alvis-Guzman, N., Amare, A. T., Ansari, H., Anwari, P., Ärnlöv, J., Asayesh, H., Asgedom, S. W., Atey, T. M., Avila-Burgos, L., Frinel, E., Avokpaho, G. A., Azarpazhooh, M. R., Barac, A., Barboza, M., Barker-Collo, S. L., Bärnighausen, T., Bedi, N., Beghi, E., Bennett, D. A., Bensenor, I. M., Berhane, A., Betsu, B. D., Bhaumik, S., Birlik, S. M., Biryukov, S., Boneya, D. J., Bulto, L. N. B., Carabin, H., Casey, D., Castañeda-Orjuela, C. A., Catalá-López, F., Chen, H., Chitheer, A. A., Chowdhury, R., Christensen, H., Dandona, L., Dandona, R., de Veber, G. A., Dharmaratne, S. D., Do, H. P., Dokova, K., Dorsey, E. R., Ellenbogen, R. G., Eskandarieh, S., Farvid, M. S., Fereshtehnejad, S.-M., Fischer, F., Foreman, K. J., Geleijnse, J. M., Gillum, R. F., Giussani, G., Goldberg, E. M., Gona, P. N., Goulart, A. C., Gugnani, H. C., Gupta, R., Hachinski, V., Gupta, R., Hamadeh, R. R., Hambisa, M., Hankey, G. J., Hareri, H. A., Havmoeller, R., Hay, S. I., Heydarpour, P., Hotez, P. J., Jakovljevic, M. (. B., Javanbakht, M., Jeemon, P., Jonas, J. B., Kalkonde, Y., Kandel, A., Karch, A., Kasaeian, A., Kastor, A., Keiyoro, P. N., Khader, Y. S., Khalil, I. A., Khan, E. A., Khang, Y.-H., Tawfih, A., Khoja, A., Khubchandani, J., Kulkarni, C., Kim, D., Kim, Y. J., Kivimaki, M., Kokubo, Y., Kosen, S., Kravchenko, M., Krishnamurthi, R. V., Defo, B. K., Kumar, G. A., Kumar, R., Kyu, H. H., Larsson, A., Lavados, P. M., Li, Y., Liang, X., Liben, M. L., Lo, W. D., Logroscino, G., Lotufo, P. A., Loy, C. T., Mackay, M. T., El Razek, H. M. A., El Razek, M. M. A., Majeed, A., Malekzadeh, R., Manhertz, T., Mantovani, L. G., Massano, J., Mazidi, M., McAlinden, C., Mehata, S., Mehndiratta, M. M., Memish, Z. A., Mendoza, W., Mengistie, M. A., Mensah, G. A., Meretoja, A., Mezgebe, H. B., Miller, T. R., Mishra, S. R., Ibrahim, N. M., Mohammadi, A., Mohammed, K. E., Mohammed, S., Mokdad, A. H., Moradi-Lakeh, M., Velasquez, I. M., Musa, K. I., Naghavi, M., Ngunjiri, J. W., Nguyen, C. T., Nguyen, G., Le Nguyen, Q., Nguyen, T. H., Nichols, E., Ningrum, D. N. A., Nong, V. M., Norrving, B., Noubiap, J. J. N., Ogbo, F. A., Owolabi, M. O., Pandian, J. D., Parmar, P. G., Pereira, D. M., Petzold, M., Phillips, M. R., Piradov, M. A., Poulton, R. G., Pourmalek, F., Qorbani, M., Rafay, A., Rahman, M., Rahman, M. H., Rai, R. K., Rajsic, S., Ranta, A., Rawaf, S., Renzaho, A. M. N., Rezai, M. S., Roth, G. A., Roshandel, G., Rubagotti, E., Sachdev, P., Safiri, S., Sahathevan, R., Sahraian, M. A., Samy, A. M., Santalucia, P., Santos, I. S., Sartorius, B., Satpathy, M., Sawhney, M., Saylan, M. I., Sepanlou, S. G., Shaikh, M. A., Shakir, R., Shamsizadeh, M., Sheth, K. N., Shigematsu, M., Shoman, H., Silva, D. A. S., Smith, M., Sobngwi, E., Sposato, L. A., Stanaway, J. D., Stein, D. J., Steiner, T. J., Stovner, L. J., Abdulkader, R. S., EI Szoeke, C., Tabarés-Seisdedos, R., Tanne, D., Theadom, A. M., Thrift, A. G., Tirschwell, D. L., Topor-Madry, R., Tran, B. X., Truelsen, T., Tuem, K. B., Ukwaja, K. N., Uthman, O. A., Varakin, Y. Y., Vasankari, T., Venketasubramanian, N., Vlassov, V. V., Wadilo, F., Wakayo, T., Wallin, M. T., Weiderpass, E., Westerman, R., Wijeratne, T., Wiysonge, C. S., Woldu, M. A., Wolfe, C. D. A., Xavier, D., Xu, G., Yano, Y., Yimam, H. H., Yonemoto, N., Yu, C., Zaidi, Z., El Sayed Zaki, M., Zunt, J. R., Murray, C. J. L., & Vos, T.
Affiliations
  • Auckland University of Technology (NZ)
  • The University of Queensland (AU)
  • Jimma University (ET)
  • University of Peradeniya (LK)
  • Mekelle University (ET)
  • Zahedan University of Medical Sciences (IR)
  • Uppsala University (SE)
  • Qom University of Medical Science and Health Services (IR)
  • Harvard University (US)
  • Jazan University (SA)
  • Instituto Nacional de Salud (CO)
  • International Institute for Population Sciences (IN)
  • Universitat de València (ES)
  • Bispebjerg Hospital (DK)
  • University of Washington (US)
  • Public Health Foundation of India (IN)
  • University of Groningen (NL)
  • Centre for Chronic Disease Control (IN)
  • Northeastern University (US)
  • University of Louisville (US)
  • Baylor College of Medicine (US)
  • University of Salerno (IT)
  • Tehran University of Medical Sciences (IR)
  • Eduardo Mondlane University (MZ)
  • Mayo Clinic (US)
  • The University of Melbourne (AU)
  • Mizan Tepi University (ET)
  • Mansoura University (EG)
  • Wuhan University (CN)
  • University of Massachusetts Boston (US)
ORCID
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2017-11
Volume
16
Issue
11
Pages
877-897
ISSN
1474-4422 (ISSN-L)
OpenAlex
W3157419554
Cited by
2,275
References
65
Citations by year
2026: 129 · 2025: 239 · 2024: 264 · 2023: 262 · 2022: 291 · 2021: 328 · 2020: 311 · 2019: 277 · 2018: 159 · 2017: 11
FWCI
284.95
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion, cc-by)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Monash University Research Portal (Monash University) (submittedVersion, cc-by)
  • Research Bank (Australian Catholic University) (submittedVersion, cc-by)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by-nc-nd)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion, other-oa)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • UCL Discovery (University College London) (submittedVersion)
  • eSpace (Curtin University) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • HZI (Helmholtz Centre for Infection Research) (submittedVersion, cc-by-nc-sa)
  • Lund University Publications (Lund University) (submittedVersion)
  • Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
  • PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion, cc-by)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
Funders
  • U.S. Department of Health and Human Services
  • Bill and Melinda Gates Foundation
  • Amgen
  • AstraZeneca
  • Massachusetts General Hospital
  • Michigan State University
  • University of Washington
  • University of Oklahoma
  • University of Rochester
  • Ottawa Hospital Research Institute
  • Arabian Gulf University
  • Wellcome Trust
  • University of Massachusetts Boston
  • Institute for Health Metrics and Evaluation
  • Trường Đại học Duy Tân
  • National Institute for Health and Care Research (ACF-2014-04-008)
  • Imperial College London
  • University of Oxford
  • Public Health Foundation of India
  • Universidad Nacional de Colombia
  • Universitat de València
  • Ministry of Business, Innovation and Employment
  • University of Toronto
  • Haramaya University
  • Universidade de São Paulo
  • Universität Bielefeld
  • Hospital for Sick Children
  • Centro de Investigación Biomédica en Red de Salud Mental
  • University of Peradeniya
  • Brain Research New Zealand
  • INCLIVA Instituto de Investigación Sanitaria
  • Debre Markos University
  • National Institutes of Health
  • College of Engineering, Michigan State University
  • University of Oklahoma Health Sciences Center
  • Medical Center, University of Rochester
  • Medical Research Council (MR/K013351/1)
  • Health Research Council of New Zealand
  • Wageningen University and Research
  • National Heart, Lung, and Blood Institute
  • National Institute on Minority Health and Health Disparities
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
neurological disorders, disease burden, disability-adjusted life years, years of life lost, years lived with disability, stroke, meningitis, encephalitis, tetanus, Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, medication overuse headache, socio-demographic index, country development level
MeSH terms
Global Burden of Disease, Cause of Death, Female, Humans, Male, Nervous System Diseases, Global Health, Quality-Adjusted Life Years

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. https://app.cochat.ai/papers/10.1016/s1474-4422(17)30299-5
The paper
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Akinyemi, R. O., Alabed, S., Al-Raddadi, R., Alvis-Guzman, N., Amare, A. T., Ansari, H., Anwari, P., Ärnlöv, J., . . . Vos, T. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(17)30299-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.